331 related articles for article (PubMed ID: 36923930)
1. The Emerging Role of Super-enhancers as Therapeutic Targets in The Digestive System Tumors.
Li XP; Qu J; Teng XQ; Zhuang HH; Dai YH; Yang Z; Qu Q
Int J Biol Sci; 2023; 19(4):1036-1048. PubMed ID: 36923930
[TBL] [Abstract][Full Text] [Related]
2. Super-enhancers complexes zoom in transcription in cancer.
Wang M; Chen Q; Wang S; Xie H; Liu J; Huang R; Xiang Y; Jiang Y; Tian D; Bian E
J Exp Clin Cancer Res; 2023 Jul; 42(1):183. PubMed ID: 37501079
[TBL] [Abstract][Full Text] [Related]
3. Super enhancer lncRNAs: a novel hallmark in cancer.
Song P; Han R; Yang F
Cell Commun Signal; 2024 Apr; 22(1):207. PubMed ID: 38566153
[TBL] [Abstract][Full Text] [Related]
4. [Research progress of super enhancer in cancer].
Wu ZQ; Mi ZY
Yi Chuan; 2019 Jan; 41(1):41-51. PubMed ID: 30686784
[TBL] [Abstract][Full Text] [Related]
5. Super-enhancers: critical roles and therapeutic targets in hematologic malignancies.
Jia Y; Chng WJ; Zhou J
J Hematol Oncol; 2019 Jul; 12(1):77. PubMed ID: 31311566
[TBL] [Abstract][Full Text] [Related]
6. The emerging role of super enhancer-derived noncoding RNAs in human cancer.
Wang Y; Nie H; He X; Liao Z; Zhou Y; Zhou J; Ou C
Theranostics; 2020; 10(24):11049-11062. PubMed ID: 33042269
[TBL] [Abstract][Full Text] [Related]
7. Super-enhancers and novel therapeutic targets in colorectal cancer.
Liu Q; Guo L; Lou Z; Xiang X; Shao J
Cell Death Dis; 2022 Mar; 13(3):228. PubMed ID: 35277481
[TBL] [Abstract][Full Text] [Related]
8. Dissecting super-enhancer driven transcriptional dependencies reveals novel therapeutic strategies and targets for group 3 subtype medulloblastoma.
Li M; Han Y; Wang C; Kang W; Jiang W; Zhang L; Tang Y
J Exp Clin Cancer Res; 2022 Oct; 41(1):311. PubMed ID: 36273157
[TBL] [Abstract][Full Text] [Related]
9. Super-enhancer in prostate cancer: transcriptional disorders and therapeutic targets.
Chen X; Ma Q; Shang Z; Niu Y
NPJ Precis Oncol; 2020 Nov; 4(1):31. PubMed ID: 33299103
[TBL] [Abstract][Full Text] [Related]
10. Super-enhancers: A new frontier for glioma treatment.
Cheng M; Zhang ZW; Ji XH; Xu Y; Bian E; Zhao B
Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188353. PubMed ID: 32112817
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets.
Bacabac M; Xu W
Cancer Metastasis Rev; 2023 Jun; 42(2):471-480. PubMed ID: 37059907
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms.
Jia Q; Chen S; Tan Y; Li Y; Tang F
Exp Mol Med; 2020 May; 52(5):713-723. PubMed ID: 32382065
[TBL] [Abstract][Full Text] [Related]
13. Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.
Liu S; Dai W; Jin B; Jiang F; Huang H; Hou W; Lan J; Jin Y; Peng W; Pan J
Mol Cancer; 2024 Jun; 23(1):122. PubMed ID: 38844984
[TBL] [Abstract][Full Text] [Related]
14. TAF Family Proteins and MEF2C Are Essential for Epstein-Barr Virus Super-Enhancer Activity.
Wang C; Jiang S; Zhang L; Li D; Liang J; Narita Y; Hou I; Zhong Q; Gewurz BE; Teng M; Zhao B
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167905
[TBL] [Abstract][Full Text] [Related]
15. Enhancer RNAs: a missing regulatory layer in gene transcription.
Mao R; Wu Y; Ming Y; Xu Y; Wang S; Chen X; Wang X; Fan Y
Sci China Life Sci; 2019 Jul; 62(7):905-912. PubMed ID: 30593613
[TBL] [Abstract][Full Text] [Related]
16. Targeting Super-Enhancer-Associated Oncogenes in Osteosarcoma with THZ2, a Covalent CDK7 Inhibitor.
Zhang J; Liu W; Zou C; Zhao Z; Lai Y; Shi Z; Xie X; Huang G; Wang Y; Zhang X; Fan Z; Su Q; Yin J; Shen J
Clin Cancer Res; 2020 Jun; 26(11):2681-2692. PubMed ID: 31937612
[TBL] [Abstract][Full Text] [Related]
17. Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma.
Zhou J; Toh SH; Tan TK; Balan K; Lim JQ; Tan TZ; Xiong S; Jia Y; Ng SB; Peng Y; Jeyasekharan AD; Fan S; Lim ST; Ong CJ; Ong CK; Sanda T; Chng WJ
Mol Cancer; 2023 Apr; 22(1):69. PubMed ID: 37032358
[TBL] [Abstract][Full Text] [Related]
18. Super enhancers as master gene regulators in the pathogenesis of hematologic malignancies.
Dębek S; Juszczyński P
Biochim Biophys Acta Rev Cancer; 2022 Mar; 1877(2):188697. PubMed ID: 35150791
[TBL] [Abstract][Full Text] [Related]
19. Super-enhancers in cancer.
Thandapani P
Pharmacol Ther; 2019 Jul; 199():129-138. PubMed ID: 30885876
[TBL] [Abstract][Full Text] [Related]
20. Super-Enhancers at the Nanog Locus Differentially Regulate Neighboring Pluripotency-Associated Genes.
Blinka S; Reimer MH; Pulakanti K; Rao S
Cell Rep; 2016 Sep; 17(1):19-28. PubMed ID: 27681417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
